Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
This report contains market size and forecasts of Wound Care Biologics in Global, including the following market information:
Global Wound Care Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Wound Care Biologics market was valued at 4054.1 million in 2021 and is projected to reach US$ 8021.6 million by 2028, at a CAGR of 10.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Biologic Skin Substitutes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wound Care Biologics include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, Derma Sciences, Inc, Soluble Systems, Amnio Technology, LLC and Medline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wound Care Biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wound Care Biologics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Wound Care Biologics Market Segment Percentages, by Type, 2021 (%)
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Global Wound Care Biologics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Wound Care Biologics Market Segment Percentages, by Application, 2021 (%)
Acute Wounds
Chronic Wounds
Surgical Wounds
Global Wound Care Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Wound Care Biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wound Care Biologics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Wound Care Biologics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Smith and Nephew
Organogenesis
MiMedx
Integra
Osiris
Derma Sciences, Inc
Soluble Systems
Amnio Technology, LLC
Medline
Skye® Biologics
Alphatec Spine,Inc.
Pinnacle Transplant Technologies